Durvalumab vs Telmisartan

## Durvalumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Telmisartan**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Telmisartan**: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Telmisartan — 24 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Telmisartan — C33H30N4O2.

**Molecular Weight**: Durvalumab — N/A; Telmisartan — 514.6230 g/mol.

**Type**: Durvalumab — Antibody; Telmisartan — Small molecule.